AQUIASFINX PROVIDES DISCOVERY SCIENTIST

Brand Owner Address Description
AQUASFINX TransForm Pharmaceuticals, Inc. 29 Hartwell Avenue Lexington MA 02421 AquiaSFinX provides the discovery scientist with a set of integrated, automated platform modules capable of running up to 1,500 parallel conditions per day to identify pharmaceutically acceptable excipient mixtures to meet the challenge of delivery of poorly water soluble drugs for animal dosing This platform can be used in early discovery and lead optimization to provide a means of very rapidly entering poorly soluble drug candidates into animal dosing Such studies can be used to determine if a compound is a potential drug candidate or simply a lead from which improved candidates can be elaborated;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and system for maintaining a discovery record and a cluster bootstrap record is provided. The discovery record enables shared storage system discovery and the cluster bootstrap record enables cluster discovery and cooperative cluster startup. The cluster bootstrap record is updated in response to a change in the cluster membership. The update is performed by a cluster leader in the form of a transactionally consistent I/O update to the cluster bootstrap record on disk and a distributed cache update across the cluster (30, 50). The update is aborted (80) in the event of a failure in the cluster leaving the cluster bootstrap record in a consistent state. In the event of a disastrous cluster and/or storage system failure, the discovery record may be recovered (228) from a restored storage system (214) and the cluster bootstrap record may be reset to install a new cluster in the old cluster's place (232).